COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

25,073 Articles (19,021 medRxiv, 6,052 bioRxiv)

Most recent first Previous |  Page 17: Articles 161-170  | Next

Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Rodriguez-Aponte, S. A., Dalvie, N. C., Wong, T. Y., Johnston, R. S., Naranjo, C. A., Bajoria, S., Kumru, O. S., Kaur, K., Russ, B. P., Lee, K. S., Cyphert, H. A., Barbier, M., Rao, H. D., Rajurkar, M. P., Lothe, R. R., Shaligram, U., Batwal, S., Chandrasekaran, R., Nagar, G., Kleanthous, H., Biswas, S., Bevere, J. R., Joshi, S. B., Volkin, D. B., Damron, F. H., Love, J. C.
10.1101/2022.09.14.507842 — Posted: 2022-09-14
The Effects of Long COVID-19, its Severity, and the Need for Immediate Attention: Analysis of Clinical Trials and Twitter data
Bhattacharyya, A., Seth, A., Rai, S.
10.1101/2022.09.13.22279833 — Posted: 2022-09-14
Real-World Effectiveness of Nirmatrelvir/Ritonavir in Preventing Hospitalization Among Patients With COVID-19 at High Risk for Severe Disease in the United States: A Nationwide Population-Based Cohort Study
Zhou, X., Kelly, S. P., Liang, C., Li, L., Shen, R., Leister-Tebbe, H., Terra, S. G., Gaffney, M., Russo, L. J.
10.1101/2022.09.13.22279908 — Posted: 2022-09-14
Trends in Low-Value Cancer Care During the COVID-19 Pandemic
Parikh, R. B., Civelek, Y., Ozluk, P., Drell, H. A., DeBono, D., Fisch, M. J., Sylwestrzak, G., Bekelman, J. E., Schwartz, A. L.
10.1101/2022.09.12.22279539 — Posted: 2022-09-14
Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing
Burkholz, S., Rubsamen, M., Blankenburg, L., Carback, R. T., Mochly-Rosen, D., Harris, P. E.
10.1101/2022.09.13.22279912 — Posted: 2022-09-14
SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in Beijing
Wang, Y., Sun, K., Pan, Y., Yi, L., Huo, D., Wu, Y., Dong, S., Guo, J., Dou, X., Wang, W., Wu, S., Bai, X., Yu, H., Wang, Q.
10.1101/2022.09.12.22279850 — Posted: 2022-09-14
The epidemiology of long COVID in US adults two years after the start of the US SARS-CoV-2 pandemic
Robertson, M., Qasmieh, S., Kulkarni, S., Teasdale, C. A., Jones, H. E., McNairy, M., Borrell, L. N., Nash, D.
10.1101/2022.09.12.22279862 — Posted: 2022-09-14
Pregnant women's attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: cross-sectional survey
Kilada, S., French, N., Perkins, E., Hungerford, D.
10.1101/2022.09.13.22279846 — Posted: 2022-09-14
The SARS-CoV-2 spike N-terminal domain engages 9-O-acetylated α2-8-linked sialic acids
Tomris, I., Unione, L., Nguyen, L., Zaree, P., Bouwman, K. M., Liu, L., Li, Z., Fok, J. A., Rios Carrasco, M., van der Woude, R., Kimpel, A. L. M., Linthorst, M. W., Verpalen, E. C. J. M., Caniels, T. G., Sanders, R. W., Heesters, B. A., Pieters, R. J., Jimenez-Barbero, J., Klassen, J. S., Boons, G.-J., de Vries, R. P.
10.1101/2022.09.14.507904 — Posted: 2022-09-14
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era
Buhler, S., Calderin, Z., Bettens, F., Schaefer, A., Dantin, C., Ansari, M., Mamez, A.-C., Masouridi-Levrat, S., Chalandon, Y., Ferrari-Lacraz, S., Villard, J.
10.1101/2022.09.14.507948 — Posted: 2022-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).